Introduction
Magnesium alloys as degradable implant materials in orthopaedic research received a lot of interest in recent years (Witte et al., 2007a; Xu et al., 2008; Zhang et al., 2010) . The application of resorbable implant material avoids an implant removal surgery and therewith helps to diminish the costs and the burden for the patient. In comparison to other degradable implant materials like polymers, magnesium alloys excel in higher tensile and compressive strength and the young's modulus is near to cortical bone (Hofmann, 1995; Staiger et al., 2006; Kaese, 2002) . Another advantage that leads to the choice of magnesium alloys as implant material is the fact, that magnesium is a natural component of the body and furthermore has many important functions within the body (Hartwig, 2001) . Magnesium is tested as non-allergenic (Witte et al., 2007a) and due to several studies it is assumed, that it stimulates new bone formation in vitro and in vivo (Revell et al., 2004; Zreitqat et al., 2002; Witte et al., 2007b) . For the application as orthopedic implant material in weight bearing bones, only magnesium alloys with a slow corrosion rate are useful. A high corrosion rate results in gas formation, a too fast loss of mechanical stability and a considerably higher bone remodelling activity (Thomann et In order to investigate if the chosen magnesium-alloys are suitable for the use in orthopedic applications, in vivo-studies in rabbit tibiae were conducted. Therefor the selected and in vitro examined magnesium alloys LAE442, WE43, MgCa0.8, AX30, ZEK100 were implanted into the rabbit tibia and examined with regard to the mechanical stability, the in vivo corrosion rate and the biocompatibility. For the in vivo investigation of the implant materials, the rabbit was used as established animal model for orthopaedic applications (Pearce, 2007) . All animal experiments were conducted under an ethic committee approved protocol in accordance with German federal welfare legislation. Five rabbits were used for each group. Extruded pins with 2.5 mm in diameter and 25 mm length were implanted into both tibiae (Fig.1a) . Four tibiae remained without implant and served as control. The used alloys contained adjacent to magnesium the elements lithium, aluminium and a rare earth composition metal (LAE442), yttrium and a rare earth composition metal (WE43), calcium (MgCa0.8), aluminium and calcium (AX30) or zinc, a rare earth composition metal and zirconium (ZEK100). The numbers describe the percentage of the alloying elements adjacent to magnesium, in accordance with the ASTM-standard. At the time of surgery, all rabbits were older than six months and hence adult. In general anaesthesia, a hole was drilled into the tibial plateau and the implant was inserted. The detailed operation procedure is described elsewhere (Thomann et al., 2009 ). Radiographs of two planes were taken immediately after surgery (Fig. 1b) . Postoperative observation periods with daily clinical and weekly radiographical examinations of three, six and in some material groups (LAE442 and MgCa0.8) twelve months were studied. During the observation period, intravital fluorescent labelling was performed (Tab. 1) and evaluated in the LAE442 group, as rare-earth containing alloy, and in the MgCa0.8 group, as calcium containing alloy, as well as in the controls. The fluorochromes calcein green (Calcein, Fa. Sigma Aldrich, Germany), calcein blue (Methylumbiliferone, Fa. Sigma Aldrich, Germany), tetracycline (Ursocyclin, Serumwerk Bernburg, Germany) and Xylenolorange (Fa. Sigma Aldrich, Germany) were used (Rahn et al., 1980 At the end of the observation period, the rabbits were euthanized and the tibiae removed. In the left tibiae, the implants were taken out for measurement of weight reduction, scanning electron microscopy (SEM) and evaluation of the mechanical stability with three point bending test. To determine the decrease of weight, the adhering organic material was For histological analysis, the samples were dehydrated and embedded in Glycolmethacrylat (Technovit 7200, Kulzer, Germany). Histological slices were prepared according to the cutting and grinding technique (Donath & Breuner, 1982) . With this technique, there was no need to decalcify the bone material, which could lead to a loss of the degradable magnesium alloy and fluorochromes prior to evaluation. Measurement of the bone remodelling and calculation of the MAR (MgCa0.8 and LAE442) was done. Therefore the distance between the different flurochrome labels, which where administered at different time points, were measured at twelve defined points within each section (Fig. 3) . A calculation of the mineral apposition rate (MAR) was possible with the following equation (Parfitt et al., 1987) : 
Results
Clinically, all tested materials were tolerated well and gas formation could not be detected. After three months all implant materials preserved their cylindrical shape with corrosion layers of different extend on the implant surface. After six months implantation time the corrosion process at the implant surfaces proceeded. With the exception of ZEK100, all implant materials still showed their cylindrical shape. ZEK100 showed cleft surfaces and losses of implant material in greater extend than in the other groups. The surfaces of MgCa0.8 (Fig 5a) , AX30 and ZEK100 were characterized by pitting corrosion. WE43 showed soil-like ablations on the surface (Fig 5b) and LAE442 homogeneous fissured corrosion (Fig. 5c) . After an implantation period of twelve months (LAE442 and MgCa0.8), MgCa0.8 was highly degraded. Only one implanted pin could be removed completely. It showed deep pits of corrosion. The other implants could be taken out in sections. In contrast, in the LAE442 group, all implants remained cylindrical to a large extend after an implantation period of six and even after an implantation period of twelve months. Uniform fissure corrosion could be observed. Bone reactions as sign of biocompatibility were less in the groups with the slower and more uniform degrading implant materials, particularly in the LAE442 group (Fig. 6 ).
In µ-computed tomography, WE43 showed inhomogeneous implant degradation and a gradual loss of the bone structure. Trabecular new bone formation could be found in the majority of µ-computed tomography slices of the bones around the implant. In the MgCa0.8 groups, after six months, bone adhesion at the implant material could be detected only sporadically. After twelve months 55% of the evaluated slices showed bone-implant contact of different degree. Some slices showed trabecular bone formation other partly or full ring bone contact around the implant material.
In the LAE442 group after six months 35% of the evaluated slices showed trabecular boneimplant contact, after twelve months 89% of the evaluated slices showed endosteal new bone formation and 53% trabecular bone-implant contact. In the histological examination polychrome sequence labelling was evaluated. In comparison to the control tibiae, the examined groups with magnesium implants showed an increased bone remodeling with a higher MAR. Especially in the first month the MAR was with 4.29µm/d in the MgCa0.8 group and with 3.36 µm/d in the LAE442 group higher than in the control group without implant material (MAR 0.87 µm/d). During the observation period, a decrease of MAR in the magnesium groups could be observed (Fig. 7) . Additionally to fluorescent labelling, the conventional histological toluidine blue staining was evaluated (Fig. 8 a-c) and after six months an irregular bone structure (Score value 1) could be observed in all examined material groups which, in the two longer observed groups, decreased with the increasing observation time. In the LAE442 group, the score value was reduced from 0.80 after six months to 0.00 after twelve months and in the MgCa0.8 group in the same period from a score value of 1.00 to 0.47 (SD 0.52). Different degrees of periosteal and endosteal remodelling were detected in all examined material groups (Tab. 3). Fibrous tissue covered less than 25% of the implant surface in all examined groups. For macrophages a score value of 1 could be observed after six months in all material groups as well as giant cells. In the MgCa0.8 group the macrophages and giant cells decreased by trend to a score of 0.8 (SD 0.41) and 0.87 (SD 0.64) after twelve months, in the LAE442 group a slight increase was found for macrophages (MV 1.17, SD 0.39) and giant cells (MV 1.08, SD 0.51). Histologically visible gas bubbles were found in all material groups after all observation periods (Tab. 3). Fig. 8 . WE 6 months (a) with an irregular bone structure with remaining implant material in the bone cavity; MgCa0.8 12 months (b, c), trabecular bone structures at the implant surface (b) and macrophages (red arrows) in the bone cavity (c), staining toluidine blue (a-c); TRAPstaining for osteoclast detection (osteoclasts = red areas) TRAP-staining was used additionally in the MgCa0.8, the WE43 and the LAE442 groups after three and six, and in the MgCa0.8 and in the LAE442 groups after twelve months to evaluate quantitative data measurement for bone remodeling activity (Fig. 9) In the calcium-containing alloy MgCa0.8 more osteoclasts could be found in all time groups, but the differences between the time and material groups after three and six months were not significant. After twelve months implantation duration the total and cortical osteoclast number was significant lower (p≤0.001) in the LAE442 group than in the MgCa0. Table 3 . Score values of histological sections in the different material groups after 6 and 12 months implantation time, staining toluidine blue, Abbreviations are described in table 2 Osteoclasts in different material groups 
Discussion
The purpose of all described studies was to investigate the applicability of different magnesium alloys as biodegradable materials in osteosynthesis. Beside an adequate primary mechanical stability and the ability to degrade without side effects, a good biocompatibility is required. Magnesium itself is described as relatively safe and assessed as non-toxic (Staiger et al., 2006) . It is an essential element for the human body and fulfils many functions in the www.intechopen.com organism. More than 300 enzymatic reactions are triggered with magnesium as part of enzymes or coenzymes and it is essential for the neuromuscular transmittance of stimuli (Topf & Murray, 2003) . About 50% of the human body-magnesium is stored in the bone. Other reservoirs for magnesium are the muscle and inner organs, especially the liver. Only about 1%is in the blood plasma. The body-magnesium is regulated by renal excretion. Since pure magnesium corrodes much too fast in vitro (Pardo et al., 2008) Zinc, as alloying element in ZEK100, can increase the tolerance limits in the magnesium alloys and reduce the effect of impurities on corrosion processes once the tolerance limit has been exceeded. Zinc overdoses can reduce the erythrocyte superoxide dismutase level, but the tolerable exposure level is with 0.83 mg kg bw -1 day -1 (Yuen & Ip, 2010 ) and with 1 wt% in the ZEK100 alloy unlikely to reach. Zirconium in magnesium alloys is used to form complexes with zinc and certain elements which are impurities (Avedesian & Baker, 1999) to improve the corrosion resistance. The daily human uptake has been known to be as high as 125 mg, toxic effects induced by very high concentrations are non-specific in nature (Ghosh et al., 1992) . Negative effects on the circumjacent bone are not described (Lit). In magnesium alloys, an exposure limit for zirconium is not known yet (Yuen & Ip, 2010) . Rare Earth metals as alloying elements in LAE442, WE43 and ZEK100 reduce the corrosion resistance by forming solid solutions or intermetallic compounds, a rare earth enrichment in the oxide film and possibly a formation of an additional magnesium hydride layer. Therefor they have beneficial effects on the castability, improve the tensile and creep properties as well as the corrosion resistance (Nakatsugawa et al., 1998). In the human body, chelated rare earths are rapidly excreted via urine, while unchelated ionic rare earths easily form colloid in blood and the colloid material is taken up by phagocytic cells of the liver and spleen. An other target organ of the rare earths is the bone, but is it not clear, what cells of the bone take up the most rare earths. The clearance of the bone is known to be very slow, but the general potential toxicity is described to be low (Hirano & Suzuki, 1996) . Based on slow degradation rates of the used alloys, toxic effects were not expected in the present studies. All implant materials used showed no clinically and radiographically observable gas generation. Even the degradation celerity in the faster degrading alloys was apparently slow enough for the body to remove the emerging gas during the corrosion process. After six months implantation duration the cylinders of all groups still existed, even all implant materials showed obvious signs of corrosion, which were different between the alloys. MgCa0.8 and WE43 degraded to a greater extend than the other materials Ax30, ZEK100 and LAE442. Especially LAE442 showed a very uniform and slow degradation process even after an observation period of 12 months. This slow degradation process of LAE442 was confirmed in other studies (Witte et al., 2009 ). The reactions of the bone could be used to evaluate the biocompatibility (Sumner-Smith & Fackelmann, 2002). After observation periods of six and twelve months, the majority of the µ-computed tomography slices of all alloys showed new endosteally based bone formation which increased in the two groups with longer observation periods (MgCa0.8 and LAE442). After 12 months the boneimplant contact with mostly trabecular bone formation was clearly stronger in the MgCa 0.8 group, although the degradation had progressed further. On the one hand a possible explanation for this divergence could be the 9% higher magnesium amount of the MgCa0.8 implants. On the other hand the calcium content could enhance the formation of precipitates of calcium and phosphorous in the implant periphery which is discussed as a possible mineralization source (Lu & Leng, 2005 Table 4 . In vivo-studies of different magnesium alloys in different animal models and with different time periods www.intechopen.com the µ-computed tomography. In both examined groups, the mineral apposition rate as sign for bone remodelling activity (Parfitt et al., 1987) was highest in the first time period (between the third and the 33th postoperative day), and even higher in the MgCa0.8 group in comparison to the LAE442-group, which was seen in the µ-computed tomography as well. A decreased MAR around magnesium scaffolds was also found in other studies (Witte et al., 2007b) . In both groups of our studies the MAR showed a decrease during postoperative time and from three to six months only marginal differences in comparison to the control, although the MAR in the MgCa0.8 group remained little higher than in the control group and the LAE442 group. The number of osteoclasts, as a sign for bone remodelling activity, which was counted in the TRAP-stained sections, confirmed these results but showed increased bone remodelling activity in the group with MgCa0.8 alloys even after twelve months implantation duration. The number of osteoclasts in the LAE442 group decreased over time albeit no significances could be found. The increased bone remodelling could be indicative of magnesium alloy induced osteoinductive properties These osteoinductive properties are supposed by other authors as well (Li et 
The high Ca 2 + and Mg 2+ contents in this degradation layer in turn accelerate the deposition of biological calcium phosphate on the surface and thereby induce the formation of new bone (Xu et al., 2007) . A further explanation for the enhanced bone remodeling activity is the regenerating effect of magnesium ions on alkaline phosphatase activity (Bonucci et al., 1992) , which is directly related to the mineralization of the osteoid matrix (Roach, 1999) . A higher bone volume per tissue volume around degrading magnesium implants and a more mature bone structure in comparison to a control group was described in other studies as well (Witte et al., 2007b; Xu et al., 2009 ). Besides the biocompatibility, the tensile strength is regarded to be the critical mechanical characteristic of an implant that is supposed to be used as implant material in weight bearing bones and to stabilize bone fragments (McKibbin, 1978) , while its ductility is of less importance (Hort et al., 2009 , Krause et al. 2010 ). As it is known and even found in the described studies, magnesium alloys have a tendency for pitting corrosion (Song et al., 2005) . These pits reduce the mechanical stability of the implant because they locally decrease the cross sectional diameter. As the calcium containing alloys have lower mechanical stabilities as shown in the described studies, for the use as implant material in weight bearing bones, the rare earth containing alloys should be preferred for these indications. All rare earth containing alloys had similar initial tensile strengths, LAE442 with 255.67 N even the highest. After 6 months, ZEK showed 41%, LAE442 and WE43 still more than 50% of their initial tensile strength. Therefor the mechanical characteristics appear suitable for the application as materials for biodegradable implants in weight bearing bones. After six months, LAE442 therefor showed a very good biocompatibility even during observation periods of 12 months, with a smooth overall impression of the bone structure, which was seen in no other material group.
It can be concluded, that magnesium alloys are very promising implant materials for orthopaedic research. Especially the rare-earth containing alloys have favourable mechanical characteristics and in particular LAE442 shows a very slow a homogeneous in vivo degradation with favourable biocompatibility even after observation periods of 12 months.
